| 2026-04-26 |
详情>>
内部人交易：
Gray DeEtte共交易2笔
|
| 2026-04-23 |
详情>>
股本变动：
变动后总股本2209.13万股
|
| 2026-04-23 |
详情>>
业绩披露：
2026年三季报(累计)每股收益17.19美元,归母净利润3.79亿美元,同比去年增长10.84%
|
| 2026-04-22 |
财报披露：
美东时间 2026-04-22 盘后发布财报
|
| 2026-01-22 |
详情>>
业绩披露：
2026年中报每股收益11.28美元,归母净利润2.49亿美元,同比去年增长8.06%
|
| 2025-10-23 |
详情>>
业绩披露：
2026年一季报每股收益5.67美元,归母净利润1.25亿美元,同比去年增长3.86%
|
| 2025-09-05 |
股东大会：
将于2025-10-16召开股东大会
会议内容 ▼▲
- 1.Election of 10 nominees named in our proxy statement to our Board of Directors to hold office until the 2026 Annual Meeting or until their respective successors have been elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To approve the CACI International Inc 2025 Incentive Compensation Plan;
4.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2026;
5.To transact such other business as may otherwise properly come before the Annual Meeting or any adjournment thereof.
|
| 2025-08-07 |
详情>>
业绩披露：
2023年年报每股收益16.59美元,归母净利润3.85亿美元,同比去年增长4.89%
|
| 2025-08-07 |
详情>>
业绩披露：
2025年年报每股收益22.47美元,归母净利润5.00亿美元,同比去年增长19.03%
|
| 2025-04-24 |
详情>>
业绩披露：
2025年三季报(累计)每股收益15.31美元,归母净利润3.42亿美元,同比去年增长19.88%
|
| 2025-01-28 |
详情>>
业绩披露：
2024年中报每股收益7.56美元,归母净利润1.70亿美元,同比去年增长-3.58%
|
| 2025-01-28 |
详情>>
业绩披露：
2025年中报每股收益10.29美元,归母净利润2.30亿美元,同比去年增长35.43%
|
| 2024-10-24 |
详情>>
业绩披露：
2025年一季报每股收益5.39美元,归母净利润1.20亿美元,同比去年增长39.66%
|
| 2024-09-06 |
股东大会：
将于2024-10-17召开股东大会
会议内容 ▼▲
- 1.Election of 11 nominees named in our proxy statement to our Board of Directors to hold office until the 2025 Annual Meeting or until their respective successors have been elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2025;
4.To transact such other business as may otherwise properly come before the Annual Meeting or any adjournment thereof.
|
| 2024-08-08 |
详情>>
业绩披露：
2024年年报每股收益18.76美元,归母净利润4.20亿美元,同比去年增长9.15%
|
| 2024-04-24 |
详情>>
业绩披露：
2024年三季报(累计)每股收益12.73美元,归母净利润2.85亿美元,同比去年增长3.00%
|
| 2023-09-08 |
股东大会：
将于2023-10-19召开股东大会
会议内容 ▼▲
- 1.Election of 11 nominees named in our proxy statement to our Board of Directors to hold office until the 2024 Annual Meeting or until their respective successors have been elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To approve on a non-binding, advisory basis the frequency of votes to approve the compensation of our named executive officers;
4.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2024;
5.To transact such other business as may otherwise properly come before the Annual Meeting or any adjournment thereof.
|
| 2022-09-08 |
股东大会：
将于2022-10-20召开股东大会
会议内容 ▼▲
- 1.Election of 11 nominees named in our proxy statement to our Board of Directors to hold office until the 2023 Annual Meeting or until their respective successors have been elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2023;
4.To transact such other business as may otherwise properly come before the Annual Meeting or any adjournment thereof.
|
| 2021-09-30 |
股东大会：
将于2021-11-11召开股东大会
会议内容 ▼▲
- 1.Election of 11 nominees named in our proxy statement to our Board of Directors to hold office until the 2022 Annual Meeting or until their respective successors have been elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2022;
4.To transact such other business as may otherwise properly come before the Annual Meeting or any adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-10-01 |
股东大会：
将于2020-11-12召开股东大会
会议内容 ▼▲
- 1.Election of eleven nominees named in our proxy statement to our Board of Directors to hold office until the 2021 Annual Meeting or until their respective successors have been elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To approve an amendment of the Company’s 2016 Amended and Restated Incentive Compensation Plan to authorize an additional 1,200,000 shares for issuance;
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2021;
5.To transact such other business as may otherwise properly come before the Annual Meeting or any adjournment thereof.
|
| 2019-10-03 |
股东大会：
将于2019-11-14召开股东大会
会议内容 ▼▲
- 1.Election of ten nominees named in our proxy statement to our Board of Directors to hold office until the 2020 Annual Meeting or until their respective successors have been elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To approve an amendment of the Company’s 2002 Employee Stock Purchase Plan to authorize an additional 250,000 shares for purchase;
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2020;
5.To transact such other business as may otherwise properly come before the Annual Meeting or any adjournment thereof.
|
| 2018-10-04 |
股东大会：
将于2018-11-15召开股东大会
会议内容 ▼▲
- 1.Election of eleven nominees named in our proxy statement to our Board of Directors to hold office until the 2019 Annual Meeting or until their respective successors have been elected and qualified;
2.To approve on a non-binding, advisory basis the compensation of our named executive officers;
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2019;
4.To transact such other business as may otherwise properly come before the Annual Meeting or any adjournment thereof.
|
| 2017-10-05 |
股东大会：
将于2017-11-16召开股东大会
会议内容 ▼▲
- (1)Election of ten nominees named in our proxy statement to our Board of Directors to hold office until the 2018 Annual Meeting or until their respective successors have been elected and qualified;
(2)To approve on a non-binding, advisory basis the compensation of our named executive officers;
(3)To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2018;
(4)To approve on a non-binding, advisory basis the frequency of future advisory votes on the compensation of our named executive officers;
(5)To transact such other business as may otherwise properly come before the Annual Meeting or any adjournment thereof.
|
| 2016-10-06 |
股东大会：
将于2016-11-17召开股东大会
会议内容 ▼▲
- (1)Election of ten nominees named in our proxy statement to our Board of Directors to hold office until the 2017 Annual Meeting or until their respective successors have been elected and qualified;
(2)To approve on a non-binding, advisory basis the compensation of our named executive officers;
(3)To approve the CACI International Inc 2016 Amended and Restated Incentive Compensation Plan;
(4)To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2017;
(5)To transact such other business as may otherwise properly come before the Annual Meeting or any adjournment thereof.
|
| 2015-10-08 |
股东大会：
将于2015-11-19召开股东大会
会议内容 ▼▲
- (1)Election of ten nominees named in our proxy statement to our Board of Directors to hold office until the 2016 Annual Meeting or until their respective successors have been elected and qualified;
(2)To approve on a non-binding, advisory basis the compensation of our named executive officers;
(3)To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2016;
(4)To transact such other business as may otherwise properly come before the Annual Meeting or any adjournment thereof.
|